DMAE (Dimethylaminoethanol) vs Sabroxy (Oroxylum indicum)

Mechanism

Structural analog of choline that crosses the BBB more readily than choline itself. Paradoxically increases choline availability not by serving as a direct precursor to acetylcholine, but by inhibiting choline metabolism in peripheral tissues, thereby increasing circulating choline available for brain uptake. Also acts as a free radical scavenger and membrane stabilizer. Reduces lipofuscin accumulation in neuronal cells, an age pigment associated with cellular aging.

Standard Dosing

150-400 mg/day (as DMAE bitartrate, typically 37% DMAE)

Timing

Morning. With or without food.

Cycle Duration

Ongoing; no strict cycling required

Side Effects

• Headache
• Insomnia
• Muscle tension
• Overstimulation
• GI discomfort
• Vivid dreams

Contraindications

• Pregnancy (potential teratogenic effects — inhibits choline incorporation into phospholipids critical for fetal neural development)
• Bipolar disorder (may worsen depressive phase)
• Epilepsy (may lower seizure threshold)

Best Stacking Partners

Mechanism

Contains oroxylin A — a flavonoid that inhibits PDE (phosphodiesterase), increases BDNF, and modulates dopamine signaling. Enhances focus and motivation without stimulant side effects. Also acts as a mild MAO-B inhibitor, preserving dopamine levels.

Contraindications

• Concurrent MAO inhibitors